InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-18.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Patel Chirag K., Co-Président. Director active across 1 company, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 4 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €367k. Activity tracked since 15 December 2021. The latest transaction was filed on 15 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
59,931 sharesClass A Common StockSEC:0001628280-26-015283:0
579,710 sharesClass A Common StockSEC:0001628280-25-010693:0
21,269,420 sharesClass A Common StockSEC:0001209191-23-054739:0
100,000 shares@ US$4.130.0096% mcap50.0% of flowClass A Common StockSEC:0001209191-21-070259:0
Canonical exit: 15 Mar 2022 (T+90)
4 of 4 declarations
About Patel Chirag K.
Chirag K. Patel is President and Co-CEO of Amneal Pharmaceuticals, Inc., a pharmaceutical company. He is responsible for the strategic direction of the company and the management of its operations. With his expertise in the pharmaceutical sector, he plays a key role in the development of new products and market expansion.
